Introducing Paragon™
FloraWorks’ discovery platform ParagonTM is a multifaceted approach to cannabinoid and cannabinoid-inspired drug development utilizing advanced chemical synthesis, biological assay screening, and cutting-edge computational tools.
Accelerating the path to discovery
FloraWorks is fast-tracking innovation with AI-assisted exploration. Combining new data with computational tools allows us to better understand the mechanisms by which cannabinoids act upon the body and their potential to bring about new therapies.
Merging rational-based drug design, artificial intelligence, and partnerships with academic and institutional researchers is helping us create a new generation of safe and effective therapeutics.
TruCBN™ Reverses Cognitive Decline in Aging Brains
In a landmark study published in Redox Biology, FloraWorks’ TruCBN™ was shown to reverse cognitive decline in aged mice.
TruCBN™ not only improved spatial learning and memory, but also enhanced mitochondrial energy production and restored key synaptic proteins like synaptophysin and PSD‑95—marking the first evidence that CBN can actively repair age-related cognitive damage.
These findings position TruCBN™ as a promising ingredient for brain health, with potential applications in slowing or reversing neurodegenerative processes.
Our research in the news
Stay ahead in the world of cannabinoid science
Join our exclusive email list for the latest insights and breakthroughs.
